Clinical Trial Update: Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluated imatinib mesylate with or without radiation therapy in children with newly diagnosed or recurrent glioma; the study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Imatinib Mesylate (Gleevec) (Imatinib mesylate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2010-04-09